On Friday, Shares of Bank of New York Mellon Corp (NYSE:BK) gained 0.13% to $45.56. The share price is trading in a range of $45.42 – 45.72. The stock exchanged hands with 3.98 million shares contrast to its average daily volume of 6.27 million shares.
A.M. Best has affirmed the Financial Strength Ratings of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a+” of BNY Trade Insurance, Ltd. (BNY Trade) (Hamilton, Bermuda) and The Hamilton Insurance Corp. (Hamilton) (Melville, NY). The outlook of these Credit Ratings (ratings) is stable.
The ratings of BNY Trade and Hamilton reflect each company’s strong risk-adjusted capitalization, consistently excellent operating performance, solid liquidity and conservative operating strategy.
Partially offsetting these positive rating factors are the companies’ limited market scope, business profile and product mix, in addition to its dependence on third parties for processing, servicing and administration. Furthermore, the companies’ maintain relatively large (gross) underwriting exposure, as they offer high-gross insurance limits and insure bankers’ professional liabilities and excess all risk property with substantial insured values.
In Addition To, the ratings recognize BNY Trade’s and Hamilton’s robust enterprise risk administration (ERM) frameworks, as they follow the ERM practices of their ultimate parent, The Bank of New York Mellon Corporation (BNY Mellon) [NYSE:BK], a leading global financial services company. The ratings also recognize the companies’ excellent business position, as a result of their close ties to BNY Mellon.
BNY Trade and Hamilton provide comprehensive reinsurance coverage and products to their parent, BNY Mellon. BNY Trade and Hamilton benefit from BNY Mellon’s noteworthyfinancial resources, in addition to extensive risk mitigation and safety programs, which have been implemented throughout the organization.
Bank of New York Mellon Corp (NYSE:BK) have shown a high EPS growth of 9.20% in the last 5 years and has earnings growth of 33.60% yoy. Analysts have a mean recommendation of 2.50 on this stock (A rating of less than 2 means buy, “hold” within the 3 range, “sell” within the 4 range, and “strong sell” within the 5 range). The stock appeared -7.64% below its 52-week highs and is down -0.24% for the last five trades.
Shares of Ocera Therapeutics Inc (NASDAQ:OCRX) declined -2.27% to $0.645. The share price of the stock plunged -76.96% for the year.
Analysts give OCRX a mean recommendation of 2.50. The company has dropped -73.67% in past 3 months and in the last five trades has moved up 8.59%. The stock has earnings growth of 4.20% yoy and showed a high EPS growth of 18.40% over the past five years. The stock’s price moved down its 200-day moving average of $2.23. The stock is presently trading down its SMA-50 of $1.68.